• HOME
  • Business
  • Stock
  • Property
  • Market
  • Economy
  • Crypto
Language:
×
  • Home
  • tags $3B deal

$3B deal News

Business

Regeneron and Fujifilm Forge $3B Biotech Alliance to Enhance US Pharmaceutical Production

Michael Lee 23 Apr, 2025

Regeneron Pharmaceuticals Inc. has signed a $3 billion deal with Fujifilm Diosynth Biotechnologies to produce biologic medicines in North Carolina, marking a significant investment...

Popular News

  • Business

    Allianz and Jio Financial Services Forge Path for New Insurance Venture in India

    21 Mar, 2025
  • Business

    Nissan-Honda Merger: A Global Move with India as a Hurdle

    24 Dec, 2024
  • Market

    Intuitive Machines Stock Plummets Over 20% Following Uncertain Lunar Landing Outcome

    07 Mar, 2025
  • Business

    Vodafone Idea Faces Insolvency: Urgent Government Support Needed to Avoid Shutdown Beyond FY26

    17 May, 2025
  • Business

    After Air India Tragedy: Soaring Anxiety Among Flyers and the Psychological Toll Unveiled

    27 Jul, 2025
  • Market

    European Markets Hold Steady Amid Ongoing US Trade Talks: What Investors Need to Know

    14 May, 2025
  • Economy

    US Oil Rig Count Drops by 2 to 486: A Weekly Decline Amidst Annual Decrease

    01 Mar, 2025
  • Economy

    Unexpected Drop: US Oil Inventories Decrease by 2.6M Barrels, Signaling Market Shifts

    15 Jan, 2025

Newsletter

Subscribe Newsletter!

Stay ahead of the market – subscribe now for the latest insights and expert analysis delivered straight to your inbox!

About Us

  • EconWatcher.com is a comprehensive financial website dedicated to providing insights into economics, stocks, real estate, cryptocurrencies, markets, and business trends.
  • 15 Cliff St, New York NY 10038, USA
  • +91 234 567 8765
  • [email protected]

Popular Categories

  • Business (1M+)
  • Stock (1M+)
  • Property (1M+)
  • Market (1M+)
  • Economy (1M+)
  • Crypto (1M+)

Legal

  • Privacy Policy

  • Terms & Conditions

  • Contact Us

Copyright © 2022 All Rights Reserved.